Breast cancer is the most prevalent cancer in the U.S., affecting almost 85 of every 100,000 Americans, according to data from the World Health Organization’s International Agency for Research on Cancer.
Time

Biopharmaceutical company Allergan is recalling rough-surface breast implants in Europe.

The company said its breast implants are safe and it's not recommending surgical removal, which can cause health problems. But it will no longer offer the "textured" version in Europe.

Smooth implants will still be sold there.

The move comes after a French regulatory agency asked the company to take action after the textured product lost its CE Mark health-and-safety certification. Some researchers have raised concerns about a cancer risk connected to certain textured implants.

Allergan said it "disagrees" with the recall reasoning but "is fully cooperating with the authority."

The company said it "has suspended sales of textured breast implants and tissue expanders and is withdrawing any remaining supply" in Europe. It will still be offered in the U.S.

A textured surface keeps the implant in place in the body. But a recent analysis of 115 research articles on lymphoma connected to breast implants raised concerns about the possibility that textured versions may be connected to higher cancer risk. About 1 in 30,000 women with breast plants get lymphoma annually.

Allergan vouched for the safety of its products, saying it had "not identified any immediate risk to the health of women with textured breast implants."

"Breast implants play a vital role for patients' physical and psychological health," said Michael Atlan, a plastic surgeon at Tenon Hospital, in a statement supplied by Allergan.

"For many patients, textured breast implants provide a critical option for surgeons to provide the right solution for each individual need. Importantly, the safety profile of textured breast implants is known and surgical removal is not being recommended on this information alone, particularly given the known risks removal can have for patients."